Malaysia's Organ Crisis: 106,000 on Dialysis by 2040, Yet Only 20 Transplants Annually
As Malaysia faces an impending healthcare disaster, it’s becoming increasingly clear that the current approach to organ donation is not enough. By 2040, the number of Malaysians requiring dialysis is projected to soar to 106,000, yet the number of available organ transplants remains shockingly low, with only 20 cadaveric transplants performed annually. The grim reality is that more than 50 Malaysians could die every single day waiting for a kidney transplant. This 2020 research paper quotes of over RM1b savings from kidney dialysis cost in 2040 if we get the organ pledging and donation going. By taking the average cost per patient, the estimated cost incurred to treat ESKD patients per year in Malaysia by 2040 is approximately RM4,381,708,760 (US$ 1,062,490,000) for dialysis, compared to RM3,286,281,570 (US$796,867,500) for transplant patients.
This crisis demands immediate action, and it’s time we consider bold, innovative solutions.
One such proposal, put forward by a group of Insurtech founders, offers a simple yet powerful way forward: providing sponsored life insurance to Malaysians who pledge to donate their organs. For just RM30 per person, organ donors would receive basic life insurance or takaful policy. This would ensure that if they pass away unexpectedly, their families are financially supported during an unimaginably difficult time.
At its core, this initiative offers a dual benefit: saving lives through organ donation and offering a crucial financial safety net for families who might otherwise struggle. By incentivizing organ pledges with life insurance coverage, we create a culture of support, where saving lives and securing financial futures go hand in hand.
The goal is ambitious - registering 1 million organ pledgers by the end of 2025. But it’s also a necessary step. The urgency of this issue cannot be overstated. If we continue down the current path, Malaysia is on the verge of a healthcare crisis where thousands of lives could be lost unnecessarily. We simply cannot afford to wait for the worst to happen.
The solution, however, is within our reach. The proposed initiative is not just a way to address the shortage of organ donors; it’s a chance to reshape the way we approach both healthcare and financial security. This is a movement that not only saves lives but also offers a sense of protection to those who need it most.
In the face of such a crisis, the question is not whether we can afford to act—it’s whether we can afford not to. We have an opportunity to make a real difference, and the time to act is now.
Let’s be part of the change and help steer Malaysia toward a future where both lives and livelihoods are safeguarded.
Ravinder Singh is the Co-Founder and Chief Commercial & Marketing Officer at AQM Technologies. He comes with 36 years of experience as a reinsurance specialist in major financial hubs including London, Amsterdam, Zurich, Singapore, and Kuala Lumpur, Ravinder is committed to making insurance affordable and inclusive. His global perspective and dedication aim to make life insurance attractive enough "to buy & not just sold."
Please note that the views expressed in this article are those of the author and do not necessarily reflect the opinions or positions of Vital Signs.
